These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Blockade of angio-associated migratory cell protein inhibits smooth muscle cell migration and neointima formation in accelerated atherosclerosis. Vogt F; Zernecke A; Beckner M; Krott N; Bosserhoff AK; Hoffmann R; Zandvoort MA; Jahnke T; Kelm M; Weber C; Blindt R J Am Coll Cardiol; 2008 Jul; 52(4):302-11. PubMed ID: 18634987 [TBL] [Abstract][Full Text] [Related]
27. Lack of evidence for antiatherogenic effects of wheat bran or corn bran in apolipoprotein E-knockout mice. Zhao Z; Xu Z; Le K; Azordegan N; Riediger ND; Moghadasian MH J Agric Food Chem; 2009 Jul; 57(14):6455-60. PubMed ID: 19601675 [TBL] [Abstract][Full Text] [Related]
28. Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice. Koga M; Kai H; Yasukawa H; Kato S; Yamamoto T; Kawai Y; Kusaba K; Seki Y; Kai M; Egashira K; Kataoka Y; Imaizumi T Hypertens Res; 2007 Mar; 30(3):259-67. PubMed ID: 17510508 [TBL] [Abstract][Full Text] [Related]
29. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr. Lloyd DJ; McCormick J; Helmering J; Kim KW; Wang M; Fordstrom P; Kaufman SA; Lindberg RA; Véniant MM Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E496-505. PubMed ID: 18160459 [TBL] [Abstract][Full Text] [Related]
31. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors. Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083 [TBL] [Abstract][Full Text] [Related]
32. Gene transfer of a broad spectrum CC-chemokine inhibitor reduces vein graft atherosclerosis in apolipoprotein E-knockout mice. Ali ZA; Bursill CA; Hu Y; Choudhury RP; Xu Q; Greaves DR; Channon KM Circulation; 2005 Aug; 112(9 Suppl):I235-41. PubMed ID: 16159823 [TBL] [Abstract][Full Text] [Related]
33. PPARgamma1-induced caveolin-1 enhances cholesterol efflux and attenuates atherosclerosis in apolipoprotein E-deficient mice. Hu Q; Zhang XJ; Liu CX; Wang XP; Zhang Y J Vasc Res; 2010; 47(1):69-79. PubMed ID: 19729954 [TBL] [Abstract][Full Text] [Related]
34. Current world literature. Curr Opin Lipidol; 2011 Aug; 22(4):308-10. PubMed ID: 21743305 [No Abstract] [Full Text] [Related]
35. [The importance of apolipoproteins in dyslipidemias]. Quintão EC Arq Bras Cardiol; 1988 Feb; 50(2):129-34. PubMed ID: 3063237 [No Abstract] [Full Text] [Related]
36. [Analysis on lipid metabolism and atherogenesis by transgenic technology]. Shimano H Tanpakushitsu Kakusan Koso; 1994 Oct; 39(13):2211-21. PubMed ID: 7972869 [No Abstract] [Full Text] [Related]
37. [Apolipoprotein E as a risk factor of coronary arteriosclerosis]. Titov VN; Nikitin SV; Tvorogova MG Kardiologiia; 1991 Jul; 31(7):71-4. PubMed ID: 1779525 [No Abstract] [Full Text] [Related]
38. [Dyslipidemias or dyslipoproteinemias? How can one detect the etiology of lipid metabolism disorders in subjects disposed to coronary accidents?]. Vastesaeger E; Vastesaeger M Brux Med; 1968 Oct; 48(10):655-60. PubMed ID: 5757970 [No Abstract] [Full Text] [Related]
39. A genetic variant of the scavenger receptor BI in humans. Khovidhunkit W N Engl J Med; 2011 Apr; 364(14):1375-6; author reply 1376. PubMed ID: 21470028 [No Abstract] [Full Text] [Related]
40. [Animal models of hypercholesterolemia: transgenic mouse/rabbit]. Fan J; Watanabe T Nihon Rinsho; 2001 Feb; 59 Suppl 2():621-5. PubMed ID: 11351661 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]